HNGE Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

13 Analyst Rating

Wall Street analysts forecast HNGE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HNGE is 66.48 USD with a low forecast of 56.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

12 Buy

1 Hold

0 Sell

Strong Buy

Current: 48.410

Low

56.00

Averages

66.48

High

90.00

Current: 48.410

Low

56.00

Averages

66.48

High

90.00

Canaccord

Buy

maintain

$61 -> $65

2025-11-05

Reason

Canaccord

Price Target

$61 -> $65

2025-11-05

maintain

Buy

Reason

Canaccord raised the firm's price target on Hinge Health to $65 from $61 and keeps a Buy rating on the shares. The firm said they posted another stellar quarter where the outlook appears favorable both in the near-term with a guidance raise that more than factors in the 3Q beat and longer-term with discussion of the potential of the new HingeSelect offering and foreshadowing of a service line expansion that may be sooner than previously anticipated.

Piper Sandler

Overweight

maintain

$70 -> $71

2025-11-05

Reason

Piper Sandler

Price Target

$70 -> $71

2025-11-05

maintain

Overweight

Reason

Piper Sandler raised the firm's price target on Hinge Health to $71 from $70 and keeps an Overweight rating on the shares. The firm notes the company reported strong Q3 results last night, with revenue and adjusted operating income exceeding the high end of guidance. The revenue beat was driven by yield and flowed through to adjusted operating income at a 93.4% incremental margin. Hinge guided Q4 ahead of consensus and raised the 2025 outlook.

Barclays

Saket Kalia

maintain

$62 -> $65

2025-11-05

Reason

Barclays

Saket Kalia

Price Target

$62 -> $65

2025-11-05

maintain

Reason

Barclays analyst Saket Kalia raised the firm's price target on Hinge Health to $65 from $62 and keeps an Overweight rating on the shares. The company reported better Q3 billings driven by expanding yields, the analyst tells investors in a research note.

Morgan Stanley

Overweight

maintain

$57 -> $67

2025-09-23

Reason

Morgan Stanley

Price Target

$57 -> $67

2025-09-23

maintain

Overweight

Reason

Morgan Stanley raised the firm's price target on Hinge Health to $67 from $57 and keeps an Overweight rating on the shares. Industry checks with Health Coaches and physical therapists confirm tech upgrades have streamlined workflows and improved member support, says the analyst, who views AI as a critical component in scaling member engagement. Rising AI effectiveness should enable growth well above the pace of operating expenses, driving margin expansion, the analyst contends.

Stifel

David Grossman

Buy

maintain

$63 -> $66

2025-09-11

Reason

Stifel

David Grossman

Price Target

$63 -> $66

2025-09-11

maintain

Buy

Reason

Stifel analyst David Grossman raised the firm's price target on Hinge Health to $66 from $63 and keeps a Buy rating on the shares. The firm's work - including investor meetings with Hinge management at the firm's Tech Summit and a proprietary benefit manager survey - suggests there is "significant momentum" behind Hinge's business, the analyst tells investors.

Baird

Vikram Kesavabhotla

Neutral

initiated

$56

2025-09-05

Reason

Baird

Vikram Kesavabhotla

Price Target

$56

2025-09-05

initiated

Neutral

Reason

Baird analyst Vikram Kesavabhotla last night initiated coverage of Hinge Health with a Neutral rating and $56 price target. The firm thinks Hinge has a "compelling" product and addresses a critical need in cutting musculoskeletal-related costs. However, Baird sees potential for the macro environment to weigh on end market demand and highlights the intensity of competition in the industry. As such, it is adopting a relatively cautious stance on Hinge shares.

Valuation Metrics

The current forward P/E ratio for Hinge Health Inc (HNGE.N) is 31.51, compared to its 5-year average forward P/E of 44.65. For a more detailed relative valuation and DCF analysis to assess Hinge Health Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

44.65

Current PE

31.51

Overvalued PE

70.40

Undervalued PE

18.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

39.53

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

68.81

Undervalued EV/EBITDA

10.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

5.80

Current PS

0.00

Overvalued PS

7.77

Undervalued PS

3.83

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

HNGE News & Events

Events Timeline

No data

News

3.0

12-09Barron's

Bullish Charts Highlight These Healthcare Stocks: GE Healthcare, STERIS, and Hinge Health

6.5

11-27NASDAQ.COM

Is Hinge Health Inc. (HNGE) Poised for a 29.59% Increase to Meet Wall Street Analysts' Expectations?

5.0

11-26Yahoo Finance

Hinge Health Executive Offloads Shares Valued at $2,116,779, Recent SEC Filing Reveals

People Also Watch

Frequently Asked Questions

What is Hinge Health Inc (HNGE) stock price today?

The current price of HNGE is 48.41 USD — it has decreased -0.19 % in the last trading day.

What is Hinge Health Inc (HNGE)'s business?

Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.

What is the price predicton of HNGE Stock?

What is Hinge Health Inc (HNGE)'s revenue for the last quarter?

Hinge Health Inc revenue for the last quarter amounts to 154.21M USD, increased 53.27 % YoY.

What is Hinge Health Inc (HNGE)'s earnings per share (EPS) for the last quarter?

Hinge Health Inc. EPS for the last quarter amounts to -0.02 USD, decreased % YoY.

What changes have occurred in the market's expectations for Hinge Health Inc (HNGE)'s fundamentals?

The market is revising Upward the revenue expectations for Hinge Health, Inc. (HNGE) for FY2025, with the revenue forecasts being adjusted by 4.24% over the past three months. During the same period, the stock price has changed by -14.68%.

How many employees does Hinge Health Inc (HNGE). have?

Hinge Health Inc (HNGE) has 1514 emplpoyees as of December 17 2025.

What is Hinge Health Inc (HNGE) market cap?

Today HNGE has the market capitalization of 3.82B USD.